Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (211-220 of 939) with videos related to

Pageof 94
Sort By:
Plant Disease|February 19, 2025
Pythium Root Rot of Wheat is not Suppressed by Indigenous 2,4-Diacetylphloroglucinol-Producing Pseudomonads in Take-All Decline SoilsRaul Allende-Molar, Tim Paulitz, Linda Thomashow, et al.
Biochemical and Biophysical Research Communications|January 20, 2007
Pirfenidone inhibits TGF-beta expression in malignant glioma cellsIsabel Burghardt, Felix Tritschler, Christiane A Opitz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 9, 2004
Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma?Rolf-Dieter Kortmann, Branislav Jeremic, Michael Weller, et al.
BMC Infectious Diseases|March 25, 2021
Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case reportJana Werner, Ina Reichen, Michael Huber, et al.
Oncology Letters|June 28, 2016
Interleukin-33 in human gliomas: Expression and prognostic significanceDorothee Gramatzki, Karl Frei, Gieri Cathomas, et al.
Journal of Neuro-Oncology|March 1, 2005
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastomaUlrich Herrlinger, Johannes Rieger, Joachim P Steinbach, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2025
Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in gliomaDaniela Lorizio, Manuela Silginer, Julia Friesen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 2, 2002
Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and AktAntje Wick, Wolfgang Wick, Johannes Waltenberger, et al.
International Journal of Oncology|September 25, 2008
Glioma gene therapy with soluble transforming growth factor-beta receptors II and IIIUlrike Naumann, Philipp Maass, Anne-Kathrin Gleske, et al.
Neuro-Oncology|December 7, 2013
Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized studyAndrea O Rossetti, Sandrine Jeckelmann, Jan Novy, et al.
Pageof 94

Showing results (211-220 of 939) with videos related to

Sort By:
Pageof 94
Plant Disease|February 19, 2025
Pythium Root Rot of Wheat is not Suppressed by Indigenous 2,4-Diacetylphloroglucinol-Producing Pseudomonads in Take-All Decline SoilsRaul Allende-Molar, Tim Paulitz, Linda Thomashow, et al.
Biochemical and Biophysical Research Communications|January 20, 2007
Pirfenidone inhibits TGF-beta expression in malignant glioma cellsIsabel Burghardt, Felix Tritschler, Christiane A Opitz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 9, 2004
Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma?Rolf-Dieter Kortmann, Branislav Jeremic, Michael Weller, et al.
BMC Infectious Diseases|March 25, 2021
Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case reportJana Werner, Ina Reichen, Michael Huber, et al.
Oncology Letters|June 28, 2016
Interleukin-33 in human gliomas: Expression and prognostic significanceDorothee Gramatzki, Karl Frei, Gieri Cathomas, et al.
Journal of Neuro-Oncology|March 1, 2005
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastomaUlrich Herrlinger, Johannes Rieger, Joachim P Steinbach, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2025
Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in gliomaDaniela Lorizio, Manuela Silginer, Julia Friesen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 2, 2002
Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and AktAntje Wick, Wolfgang Wick, Johannes Waltenberger, et al.
International Journal of Oncology|September 25, 2008
Glioma gene therapy with soluble transforming growth factor-beta receptors II and IIIUlrike Naumann, Philipp Maass, Anne-Kathrin Gleske, et al.
Neuro-Oncology|December 7, 2013
Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized studyAndrea O Rossetti, Sandrine Jeckelmann, Jan Novy, et al.
Pageof 94